Screener
Candel Therapeutics, Inc. CADL Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$38.91M-711% | -$8.86M-220% | -$29.5M-110% | -$11.27M-5.9% | -$4.8M+78.4% | ||
| $200K0.0% | $149K-39.2% | $163K-33.5% | $200K0.0% | $200K0.0% | ||
| $2.86M+172% | $1.45M+362% | $1.29M+3.7% | $1.16M-1.8% | $1.05M-43.0% | ||
| -$17.18M-93.3% | -$18.04M-109% | -$10.57M-81.8% | -$10.24M-55.7% | -$8.89M-43.4% | ||
| $69K+123% | $675K+22,400% | $409K+13,533% | $144K— | $31K+417% | ||
| -$69K-123% | -$675K-22,400% | -$409K-13,533% | -$117K— | -$31K-417% | ||
| $23.98M+37.5% | $93.82M+5,117% | $43.9M-52.2% | $0-100% | $17.44M+797% | ||
| $6.73M-21.0% | $75.1M+816% | $32.92M-61.8% | -$13.72M-180% | $8.52M+300% | ||
| -$17.25M-93.4% | -$18.71M-117% | -$10.98M-88.7% | -$10.38M-57.9% | -$8.92M-43.8% |
FAQ
- How much cash does Candel Therapeutics, Inc. generate?
- Candel Therapeutics, Inc. (CADL) generated -$56.0M in operating cash flow over the trailing twelve months.
- What is Candel Therapeutics, Inc.'s free cash flow?
- After $1.3M of capital expenditures, Candel Therapeutics, Inc.'s free cash flow was -$57.3M over the trailing twelve months, down 91.5% year over year.
- Where does Candel Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Candel Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.